We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




TF-Test Modified as New Diagnostic Tool for Human Enteroparasitosis

By LabMedica International staff writers
Posted on 01 Jul 2015
Print article
Image: Blastocystis hominis cyst-like forms in wet mounts under differential interference contrast (DIC) microscopy (Photo courtesy of Centers for Disease Control and Prevention).
Image: Blastocystis hominis cyst-like forms in wet mounts under differential interference contrast (DIC) microscopy (Photo courtesy of Centers for Disease Control and Prevention).
Intestinal parasitosis is highly prevalent worldwide, being among the main causes of illness and death in humans and currently, laboratory diagnosis of the intestinal parasites is accomplished through manual technical procedures, mostly developed decades ago, which justifies the development of more sensitive and practical techniques.

The three fecal tests (TF-Test) conventional parasitological technique has been providing effective and practical enteroparasitosis diagnosis for clinical analysis laboratories, especially by collecting three separate stool samples on alternate days and processing them at once with the laboratory procedure of parasite concentration and elimination of fecal debris by the principle of centrifugal sedimentation.

Scientists at the University of Campinas (São Paulo, Brazil) collected a total of 457 stool samples which were obtained from two sources in enteroparasitosis endemic areas. One source was from 185 children aged between 9 months and 7 years, who were enrolled in two municipal elementary schools located in the southwestern region of Campinas. The other source was from 272 individuals aged between four and 72 years, who attended public basic health units located in the south and southeastern regions in the municipality of Campinas. Samples were collected in TF-Test collector tubes for subsequent laboratory processing.

The new parasitological technique referred to as TF-Test Modified, was compared to three conventional parasitological techniques: TF-Test Conventional; Rugai, Mattos & Brisola; and Helm Test/Kato-Katz. Among the stool samples of 457 volunteers, 1,828 tests were performed by the four parasitological techniques resulting in detection of 14 species, from which six were related to protozoa and eight related to intestinal helminths. The sum of positive cases of all four techniques was 308 parasitic structures, including cysts, eggs, and larvae. Among them, 303 were identified by TF-Test Modified, 256 by TF-Test Conventional, 23 by Helm Test, and 19 by Rugai, Mattos & Brisola technique.TF-Test Modified allowed the preparation of temporary smears stained with Lugol's iodine solution, with a high concentration of parasite species, and largely free of fecal debris and leading to the diagnosis of Blastocystis hominis and other protozoa, by giving a sharper image.

The authors concluded that the modifications added to this new diagnostic technique provided high diagnostic values, increasing the sensitivity by 15.26% when compared to the second-best technique, TF-Test Conventional. The present study demonstrated that the TF-Test Modified technique can be comprehensively used in qualitative diagnosis of humans’ intestinal helminths and protozoa. The gain in diagnostic sensitivity provided by this new technique should have a laudable contribution to the laboratorial diagnosis, population surveys, and intestinal parasites control. The study was first published online on May 15, 2015, in the Journal of Clinical Laboratory Analysis.

Related Links:

University of Campinas  


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.